DAPK1 and primary central nervous system lymphoma: Here, we present data on a large cohort of 107 consecutively diagnosed PCNSL cases, with comprehensive analyses of clinical data, histopathology, TP53 mutation status, and MIR34A/B/C and DAPK promoter methylation.